Helios Fairfax Reports Q2 2024 Financial Resultsby Mark Eisenberg 10.08.2024Helios Fairfax sees strong investment performance despite a net loss of $16.5 million in Q2 2024, driven by unrealized losses.
Investing in Psychedelics for Net Zero Traumaby Mark Eisenberg 11.01.2024Investors are turning to psychedelics as a game-changer for mental health. The recent $100 million financing for Lykos Therapeutics shows ...